Karen M. Kumor
Directeur Technique/Scientifique/R&D chez Sapphire Therapeutics, Inc.
Profil
Karen M.
Kumor is currently working as Vice President-Clinical Research at Sapphire Therapeutics, Inc. She has a graduate and doctorate degree from The Johns Hopkins University.
Postes actifs de Karen M. Kumor
| Sociétés | Poste | Début |
|---|---|---|
Sapphire Therapeutics, Inc.
 Sapphire Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Sapphire Therapeutics, Inc. develops biopharmaceutical products. It develops compounds for the treatment of oncologic and metabolic diseases. The firm products include anamorelin for the treatment of anorexia and cachexia. The company was founded in 2000 and is headquartered in Bridgewater, NJ. | Directeur Technique/Scientifique/R&D | 12/10/2009 |
Formation de Karen M. Kumor
| The Johns Hopkins University | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 1 |
|---|---|
Sapphire Therapeutics, Inc.
Sapphire Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Sapphire Therapeutics, Inc. develops biopharmaceutical products. It develops compounds for the treatment of oncologic and metabolic diseases. The firm products include anamorelin for the treatment of anorexia and cachexia. The company was founded in 2000 and is headquartered in Bridgewater, NJ. | Health Technology |
